Crossmark

Transnational pharmacogovernance: emergent patterns in the jazz of pharmaceutical policy convergence

Crossref DOI link: https://doi.org/10.1186/s12992-018-0402-5

Published Online: 2018-08-22

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wiktorowicz, Mary http://orcid.org/0000-0001-7539-2043
Moscou, Kathy

Lexchin, Joel
Funding

Funding for this research was provided by:

Canadian Institutes of Health Research

Health Council of Canada

Canadian Patient Safety Institute
License Information

Text and Data Mining valid from 2018-08-22
More Information

Article History

Received: 27 April 2018

Accepted: 30 July 2018

First Online: 22 August 2018

Ethics approval and consent to participate

: Ethics approval was attained from the York University Ethics Committee, ethics certificate e2015–141. Informed consent was attained from all key informants who agreed to participate in interviews for this research.

: Not applicable.

: JL received payment from two non-profit organizations for being a consultant on a project looking at indication-based prescribing and a second looking at which drugs should be distributed free of charge by general practitioners in 2015–2017. JL received payment from a for-profit organization for being on a panel that discussed expanding drug insurance in Canada in 2015, and is on the Foundation Board of Health Action International.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.